Published in Transfusion on June 12, 1975
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Risk of venous thromboembolism in users of hormone replacement therapy. Lancet (1996) 2.92
IMGT, the international ImMunoGeneTics database. Nucleic Acids Res (1997) 2.43
Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol (1980) 2.31
The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J (1978) 2.28
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
The stereochemistry of the hydrogen elimination in the biological conversion of cholest-7-en-3-beta-ol into cholesterol. Biochem J (1967) 1.98
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Axonal GABA-receptors in mammalian peripheral nerve trunks. Brain Res (1978) 1.97
Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther (2008) 1.54
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
Automation in the blood transfusion laboratory: I. Antibody dectection and quantitation in the technicon autoanalyzer. Can Med Assoc J (1969) 1.43
Counter-immunoelectrophoresis for detection of hepatitis B antigen and antibody: a technique for large-scale use. Can J Public Health (1973) 1.42
Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med (1991) 1.41
Good laboratory practice before blood transfusion. Can Med Assoc J (1984) 1.39
Measles immunisation. Aust J Public Health (1992) 1.38
Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet Rec (2003) 1.37
A very simple method for recording ganglion depolarization. J Physiol (1975) 1.36
Current concepts in the development of heterotopic ossification. J Bone Joint Surg Br (2004) 1.32
Incidence of hepatitis B antigen and antibody among Canadian volunteer blood donors. Can Med Assoc J (1972) 1.30
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics. Clin Pharmacol Ther (2007) 1.28
Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway. Pharmacogenomics J (2004) 1.27
Indirect effects of amino-acids on sympathetic ganglion cells mediated through the release of gamma-aminobutyric acid from glial cells. Br J Pharmacol (1976) 1.25
Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med (2000) 1.23
Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Clin Pharmacol Ther (2007) 1.16
An international proficiency survey for the detection of hepatitis B antigen and antibody in blood donations by counterimmunoelectrophoresis. Vox Sang (1974) 1.10
Operative stabilization of nonpenetrating chest injuries. J Thorac Cardiovasc Surg (1975) 1.07
Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet (1994) 1.07
Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors. Cancer Res (1998) 1.06
Population variation in VKORC1 haplotype structure. J Thromb Haemost (2006) 1.05
Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer (2001) 1.04
Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res (2001) 1.04
Reappraisal of an autoanalyzer haemagglutination system for anti-D quantification. Scand J Haematol (1972) 1.03
Ethnic differences in pharmacogenetically relevant genes. Curr Drug Targets (2006) 1.00
Angiotensin mimics the action of muscarinic agonists on rat sympathetic neurones. Brain Res (1980) 0.97
A family demonstrating inheritance of the Leach phenotype: a Gerbich-negative phenotype associated with elliptocytosis. Vox Sang (1986) 0.95
Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J (2010) 0.95
Influence of local vascularity on hormone receptors in mammary gland. Nature (1980) 0.94
Pulmonary arterio-venous fistula. Thorax (1969) 0.94
The glycerol kinase gene family: structure of the Xp gene, and related intronless retroposons. Hum Mol Genet (1994) 0.94
Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib. Clin Pharmacol Ther (2007) 0.94
An integrated YAC map of the human X chromosome. Genome Res (1996) 0.93
Curve regenerationin modified LISP and DISP AutoAnalyzer haemagglutination channels. J Clin Pathol (1979) 0.92
Characterization of the topoisomerase I locus in human colorectal cancer. Cancer Genet Cytogenet (2000) 0.92
Crohn's disease: ethnic variation in CARD15 genotypes. Gut (2003) 0.91
Smoking and COPD: What really are the risks? Eur Respir J (2006) 0.91
Experimental classical bovine spongiform encephalopathy: definition and progression of neural PrP immunolabeling in relation to diagnosis and disease controls. Vet Pathol (2010) 0.90
Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology (2004) 0.90
Practical application of synthetic A and B blood group immunoadsorbents. Rev Fr Transfus Immunohematol (1981) 0.89
Distribution of gaba-receptors and gaba-carriers in the mammalian nervous system. J Physiol (Paris) (1979) 0.89
Helping the employee victim of violence in hospitals. Hosp Community Psychiatry (1986) 0.89
Haptoglobin genotype as a risk factor for diabetic retinopathy. JAMA (2000) 0.89
Mortality from renal disease in Israel. Some epidemiological aspects. J Chronic Dis (1970) 0.88
Replicate tests for the detection and correction of errors in anti-human globulin (AHG) tests: optimum conditions and quality control. Haematologia (Budap) (1988) 0.87
Actions of GABA on mammalian neurones, axons, and nerve terminals. Adv Biochem Psychopharmacol (1981) 0.87
Expression of keratinocyte growth factor and its receptor in human breast cancer. Br J Cancer (1997) 0.85
Influence of ethnicity on pharmacogenetic variation in the Ghanaian population. Pharmacogenomics J (2009) 0.84
Hepatitis B antigenemia among blood donors: the changing scene. Can Med Assoc J (1975) 0.84
PVP-augmented LISP and DISP AutoAnalyzer haemagglutination channels. J Clin Pathol (1979) 0.84
Proficiency in the detection and titration of blood group antibodies: results of an interlaboratory trial. Can Med Assoc J (1970) 0.83
Quality of life post radical prostatectomy: a male perspective. Urol Nurs (2001) 0.83
Metabolism and binding of benzo(a)pyrene and 2-acetylaminofluorene by short-term organ cultures of human and rat bladder. Cancer Res (1982) 0.83
CSF 5-HIAA and nighttime activity in free-ranging primates. Neuropsychopharmacology (2000) 0.82
Prevalence of HB Ag and HB Ab in the Canadian blood-donor population. Haematologia (Budap) (1974) 0.81
The impact of different time frames of risk communication on Type 2 diabetes patients' understanding and memory for risk of coronary heart disease and stroke. Diabet Med (2008) 0.81
Behind the scenes: partners' perceptions of quality of life post radical prostatectomy. Urol Nurs (2000) 0.81
Distribution and activation of T-lymphocyte subsets in tuberculous bovine lymph-node granulomas. Vet Pathol (2007) 0.80
Pharmacogenetically relevant polymorphisms in Portugal. Pharmacogenomics (2007) 0.80
Metabolism of benzo(a)pyrene and its major metabolites to ethyl acetate-soluble and water-soluble metabolites by cultured rodent trachea. Cancer Res (1978) 0.80
Short-term response to counseling and case management intervention in a domestic violence shelter. Psychol Rep (1997) 0.80
Interethnic variability of ERCC2 polymorphisms. Pharmacogenomics J (2005) 0.79
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs. J Vet Pharmacol Ther (2010) 0.79
The metabolism of benzo(a)pyrene, 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene and 9,10-dihydro-9,10-dihydroxybenzono leads to (a)pyrene by short-term organ cultures of hamster lung. Biochem Pharmacol (1977) 0.79
Metabolism of (3H)benzo(a)pyrene by different portions of the respiratory tract. Biochem Pharmacol (1976) 0.79
Comparison of fatalities from work related motor vehicle traffic incidents in Australia, New Zealand, and the United States. Inj Prev (2005) 0.79
The recessive Lu(a-b-) phenotype. A family study. Vox Sang (1974) 0.79
HHV-6 infection in HIV-infected asymptomatic and AIDS patients. Intervirology (1998) 0.79
Disaster triage after the Haitian earthquake. Injury (2011) 0.79
Immunoglobulin lambda light chain orphons on human chromosome 8q11.2. Eur J Immunol (1997) 0.78
Mammary-tumour incidence in Sprague-Dawley rats treated with 7,12-dimethylbenz(a)anthracene: effect of pregnancy and lack of effect of unilateral lactation. Br J Cancer (1981) 0.78
Studies on the metabolism and excretion of benzo(a)pyrene in isolated adult rat hepatocytes. Biochem Pharmacol (1978) 0.78
Benzo(a)pyren-3-yl hydrogen sulphate, a major ethyl acetate-extractable metabolite of benzo(a)pyrene in human, hamster and rat lung cultures. Biochem Pharmacol (1976) 0.78
Organic solvent soluble sulphate ester conjugates of monohydroxybenzo(a)pyrenes. Biochem Pharmacol (1977) 0.77
Streamlining outpatient urogynaecology: a novel approach. J Obstet Gynaecol (2011) 0.77
Prevalence of HBsAg and HBsAg sub-types in the Canadian blood-donor population. Rev Fr Transfus Immunohematol (1979) 0.77
Localization of the human kinesin light chain gene (KNS2) to chromosome 14q32.3 by fluorescence in situ hybridization. Genomics (1996) 0.77
Dihydromatricariate-based triglycerides, glyceride ethers, and waxes in the australian soldier beetle,Chauliognathus lugubris (Coleoptera: Cantharidae). J Chem Ecol (1988) 0.77
gamma-Aminobutyric acid efflux from sympathetic glial cells: effect of 'depolarizing' agents. J Physiol (1979) 0.77
Classification of weak variants of blood-group A. Rev Fr Transfus Immunohematol (1976) 0.77
Carcinogenicity and metabolic profiles of 3-methylcholanthrene oxygenated derivatives at the 1 and 2 positions. Chem Biol Interact (1978) 0.77
The non-covalent binding of benzo[a]pyrene and its hydroxylated metabolites to intracellular proteins and lipid bilayers. Chem Biol Interact (1980) 0.77
Long-term community non-invasive ventilation. Intern Med J (2010) 0.77
Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme. Colorectal Dis (2007) 0.76
Action of GABA on mammalian peripheral nerves [proceedings]. J Physiol (1978) 0.76
Hepatitis markers detected in a Canadian blood donor population. Acta Haematol Pol (1980) 0.76
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies. Ann Oncol (2008) 0.75
Pan- and auto-agglutination in albumin: a serological and immunochemical study of five cases. Immunology (1968) 0.75
Hyperparathyroidism and increased serum IGF-binding protein-2 levels in hepatitis C-associated osteosclerosis. J Clin Endocrinol Metab (1999) 0.75
Automation in the blood transfusion laboratory. II. ABO grouping, Rh and Kell typing, antibody screening, and VD testing of blood donations in the autoanalyzer. Can Med Assoc J (1969) 0.75